Updated results from the four studies will be presented in Oral Reports or Posters at the ASCO Annual Meeting
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
Almost 300 million people globally have chronic hepatitis B
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
The ANDA was filed as 'First to File' submission on NCE-1 date.
Subscribe To Our Newsletter & Stay Updated
